MTHRY
Get informed when a big investor buys or sells
+ FollowUndervalued by 75.1% based on the discounted cash flow analysis.
| Market cap | $6.66 Billion |
|---|---|
| Enterprise Value | $-116,900,650,499.00 |
| Dividend Yield | $0.07 (1.37%) |
| Earnings per Share | $38.35 |
| Beta | 0.47 |
| Outstanding Shares | 1,341,334,000 |
| P/E Ratio | 21.98 |
|---|---|
| PEG | -495.66 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | -0.43 |
| Enterprise Value to EBIT | -1.85 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | -0.28 |
| Debt to Equity | 0.08 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
This committee directly allocates discretionary federal spending. Its subcommittees determine the specific funding levels for defense, scientific research, and other programs that are key clients for M3's R&D services.
This committee directly oversees the Department of Defense and authorizes the NDAA, determining significant R&D funding for military technologies, a prime area for engineering and physical sciences R&D contractors like M3.
This committee has explicit jurisdiction over 'Science' and interstate commerce, often funding scientific research and setting regulations that impact technology and R&D-intensive industries, including aerospace and transportation engineering.
This committee directly oversees federal contracting and government procurement, which is a primary revenue stream for a company providing professional, scientific, and technical R&D services to the government.